JUSQX
Price
$19.26
Change
-$0.11 (-0.57%)
Updated
Oct 17 closing price
Net Assets
961.51M
VSMAX
Price
$121.32
Change
-$0.03 (-0.02%)
Updated
Oct 17 closing price
Net Assets
162.36B
Interact to see
Advertisement

JUSQX vs VSMAX

Header iconJUSQX vs VSMAX Comparison
Open Charts JUSQX vs VSMAXBanner chart's image
JPMorgan US Small Company R4
Price$19.26
Change-$0.11 (-0.57%)
VolumeN/A
Net Assets961.51M
Vanguard Small Cap Index Admiral Shares
Price$121.32
Change-$0.03 (-0.02%)
VolumeN/A
Net Assets162.36B
JUSQX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
JUSQX vs. VSMAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JUSQX is a Buy and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 162B vs. JUSQX (962M). VSMAX pays higher dividends than JUSQX: VSMAX (1.34) vs JUSQX (0.29). JUSQX was incepted earlier than VSMAX: JUSQX (9 years) vs VSMAX (25 years). JUSQX (0.97) is less costly to investors than VSMAX (0.05). JUSQX is a more actively managed with annual turnover of: 104.00 vs. VSMAX (13.00). JUSQX has a lower initial minimum investment than VSMAX: JUSQX (0) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 4.95 vs. JUSQX (-2.25). VSMAX return over 5 years is better than : 55.46 vs. JUSQX (9.73).
JUSQXVSMAXJUSQX / VSMAX
Total Expense Ratio0.970.051,940%
Annual Report Gross Expense Ratio0.970.051,940%
Fund Existence9 years25 years-
Gain YTD7.8995.599141%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets962M162B1%
Annual Yield % from dividends0.291.3422%
Returns for 1 year-2.254.95-46%
Returns for 3 years23.9442.0257%
Returns for 5 years9.7355.4618%
Returns for 10 yearsN/A130.86-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYRE22.470.23
+1.03%
Spyre Therapeutics
DVA125.880.63
+0.50%
DaVita
HVIIU10.71N/A
N/A
Hennessy Capital Investmnt Corp VII
CIVB19.97-0.03
-0.15%
Civista Bancshares
LUNG1.52-0.05
-3.18%
Pulmonx Corp